Chemotherapy remains an important option for advanced prostate cancer, especially when disease becomes resistant to hormonal therapy or in selected men with extensive metastatic disease. This update explains when chemo is used, common drugs, side effects, and how it fits with newer targeted and immune therapies.
An updated overview of prostate cancer management: screening choices, active surveillance, local and systemic treatments including newer targeted and radioligand therapies, and realistic guidance on diet, supplements, and lifestyle.
Practical, evidence-based ways to manage prostate cancer: how surveillance, surgery, radiation, systemic drugs, lifestyle, and mental-health support fit together.
Prostate cancer treatment is individualized by stage and risk. Early disease may be monitored with active surveillance or treated with surgery or radiation. Advanced disease relies on androgen-deprivation, systemic targeted agents, chemotherapy, and radioligand therapy, with decisions guided by biomarkers and patient goals.